HomeCompareNAYA vs XYLD

NAYA vs XYLD: Dividend Comparison 2026

NAYA yields 90.91% · XYLD yields 10.98%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NAYA wins by $2.64M in total portfolio value
10 years
NAYA
NAYA
● Live price
90.91%
Share price
$2.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.67M
Annual income
$842,999.04
Full NAYA calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
10.98%
Share price
$39.13
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$3,219.02
Full XYLD calculator →

Portfolio growth — NAYA vs XYLD

📍 NAYA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNAYAXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NAYA + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NAYA pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NAYA
Annual income on $10K today (after 15% tax)
$7,727.27/yr
After 10yr DRIP, annual income (after tax)
$716,549.18/yr
XYLD
Annual income on $10K today (after 15% tax)
$933.63/yr
After 10yr DRIP, annual income (after tax)
$2,736.17/yr
At 15% tax rate, NAYA beats the other by $713,813.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NAYA + XYLD for your $10,000?

NAYA: 50%XYLD: 50%
100% XYLD50/50100% NAYA
Portfolio after 10yr
$1.35M
Annual income
$423,109.03/yr
Blended yield
31.43%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NAYA buys
0
XYLD buys
0
No recent congressional trades found for NAYA or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNAYAXYLD
Forward yield90.91%10.98%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$2.67M$25.3K
Annual income after 10y$842,999.04$3,219.02
Total dividends collected$2.36M$19.6K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: NAYA vs XYLD ($10,000, DRIP)

YearNAYA PortfolioNAYA Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$19,791$9,090.91$10,818$1,098.39+$9.0KNAYA
2$37,991$16,814.71$11,738$1,222.51+$26.3KNAYA
3$70,817$30,166.17$12,774$1,364.64+$58.0KNAYA
4$128,326$52,552.16$13,944$1,527.86+$114.4KNAYA
5$226,308$88,999.24$15,270$1,715.87+$211.0KNAYA
6$388,835$146,685.82$16,775$1,933.09+$372.1KNAYA
7$651,597$235,543.05$18,490$2,184.87+$633.1KNAYA
8$1,066,101$368,892.48$20,450$2,477.63+$1.05MNAYA
9$1,704,801$564,073.19$22,697$2,819.19+$1.68MNAYA
10$2,667,136$842,999.04$25,280$3,219.02+$2.64MNAYA

NAYA vs XYLD: Complete Analysis 2026

NAYAStock

INVO Bioscience is a medical device company providing devices and products for infertility diagnosis. Its flagship product is INVOcell, a reproductive technology that allows fertilization and early embryo development to take place within the woman’s body.

Full NAYA Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this NAYA vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NAYA vs SCHDNAYA vs JEPINAYA vs ONAYA vs KONAYA vs MAINNAYA vs QYLDNAYA vs JEPQNAYA vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.